Keyes Jason A
- SEC CIK
- 0001678152
In the past year, 1 open-market purchase filing worth $11.2K and no sales.
Current role at each company
- BLSM BlossomHill Therapeutics, Inc.Chief Financial Officeras of Aug 10, 2026
- ACTU Actuate Therapeutics, Inc.Directoras of May 22, 2026
- EQ Equillium, Inc.Chief Financial Officeras of Feb 19, 2025
- CARM Carisma Therapeutics Inc.Directoras of Jun 24, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $11.2K
- 1 filing
- Sold
- –
- 0 filings
- Net
- +$11.2K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Keyes Jason A as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
BLSM BlossomHill Therapeutics, Inc.
Chief Financial Officer1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 10, 2026 (view filing)6:27 PM ET | Aug 10 | Same day | Keyes Jason AChief Financial Officer | PPurchase | +700 | $16.00 | +$11.2K | New position700 after |
EQ Equillium, Inc.
Chief Financial Officer10 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 24, 2025 (view filing) | Jan 23 | 1 day | Keyes Jason AChief Financial Officer | SSale | −10.0K | $0.65 | −$6.50K | −21.0%37.7K after | 10b5-1 |
| Nov 15, 2024 (view filing) | Nov 14 | 1 day | Keyes Jason AChief Financial Officer | SSale | −10.0K | $0.70 | −$7.00K | −17.3%47.7K after | 10b5-1 |
| Sep 27, 2024 (view filing) | Sep 26 | 1 day | Keyes Jason AChief Financial Officer | SSale | −10.0K | $0.81 | −$8.10K | −14.8%57.7K after | 10b5-1 |
| Jul 18, 2024 (view filing) | Jul 16 | 2 days | Keyes Jason AChief Financial Officer | SSale | −10.0K | $0.87 | −$8.70K | −12.9%67.7K after | 10b5-1 |
| Aug 30, 2022 (view filing) | Aug 29 | 1 day | Keyes Jason AChief Financial Officer | SSale | −7.00K | $2.83 | −$19.8K | −8.3%77.7K after | |
| Jun 6, 2022 (view filing) | Jun 6 | Same day | Keyes Jason AChief Financial Officer | SSale | −5.00K | $2.52 | −$12.6K | −5.6%84.7K after | |
| Apr 5, 2022 (view filing) | Apr 4 | 1 day | Keyes Jason AChief Financial Officer | SSale | −8.00K | $3.18 | −$25.4K | −8.2%89.7K after | |
| Dec 3, 2021 (view filing) | Dec 1 | 2 days | Keyes Jason AChief Financial Officer | SSale | −5.00K | $5.08 | −$25.4K | −4.9%97.7K after | |
| Sep 29, 2021 (view filing) | Sep 27 | 2 days | Keyes Jason AChief Financial Officer | SSale | −8.00K | $6.74 | −$53.9K | −7.2%102.7K after | |
| Jul 28, 2021 (view filing) | Jul 27 | 1 day | Keyes Jason AChief Financial Officer | SSale | −5.00K | $5.72 | −$28.6K | −4.3%110.7K after |